Survival Impact of Pathological Residual Patterns for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy

2026-06-25

PRE

Hidetaka Miyazaki

Mitsuaki Ishida

Nguyen Thanh Sang

Hiroyuki Ishida

Katsunori Uchida

Daisuke Hashimoto

Sohei Satoi

DOI：10.1002/jhbp.70146

Original

Original request for help

Save

Abstract

En 中文

With increasing use of neoadjuvant therapy (NAT) for pancreatic ductal adenocarcinoma (PDAC), accurate pathological response system is essential. Although the College of American Pathologists (CAP) grading is widely used, its prognostic utility remains limited.

Keywords:

College of American Pathologists grading system

neoadjuvant therapy

pancreatic ductal adenocarcinoma

pathological response system

residual patterns

Survival Impact of Pathological Residual Patterns for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy

Abstract

Journal

Organization

Cited Papers

Citing Papers